NCIC Clinical Trials Group: all 116 studies
Page 2 of 2. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Theophylline in Treating Cancer Patients With Shortness of BreathCompletedNCT00003684Phase 3
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerCompletedNCT00003653Phase 3
- Topotecan in Treating Patients With Recurrent Brain TumorsCompletedNCT00003372Phase 2
- Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate CancerCompletedNCT00003232Phase 3
- Letrozole After Tamoxifen in Treating Women With Breast CancerCompletedNCT00003140Phase 3
- High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00003032Phase 3
- Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedNCT00003011Phase 3
- Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast CancerCompletedNCT00002866Phase 1
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00002864Phase 3
- Radiation or Observation Only in Endometrial Cancer Who Have Undergone SurgeryCompletedNCT00002807Not applicable
- Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00002678Phase 3
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00002633Phase 3
- Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically RemovedCompletedNCT00002583Phase 3
- Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of DiseaseCompletedNCT00002570Phase 3
- Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's DiseaseCompletedNCT00002561Phase 3
- Tamoxifen in Treating Women With High-Risk Breast CancerCompletedNCT00002542Phase 3